E. Laskos

465 total citations
9 papers, 398 citations indexed

About

E. Laskos is a scholar working on Cellular and Molecular Neuroscience, Cognitive Neuroscience and Developmental Neuroscience. According to data from OpenAlex, E. Laskos has authored 9 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 6 papers in Cognitive Neuroscience and 5 papers in Developmental Neuroscience. Recurrent topics in E. Laskos's work include Nerve injury and regeneration (6 papers), Autism Spectrum Disorder Research (6 papers) and Neurogenesis and neuroplasticity mechanisms (5 papers). E. Laskos is often cited by papers focused on Nerve injury and regeneration (6 papers), Autism Spectrum Disorder Research (6 papers) and Neurogenesis and neuroplasticity mechanisms (5 papers). E. Laskos collaborates with scholars based in Greece, United Kingdom and Armenia. E. Laskos's co-authors include Emmanouil� Rizos, Lefteris Lykouras, Anastasia Kastania, Panayiota G. Michalopoulou, Rossetos Gournellis, George Arsenis, Αθανασία Παπαδοπούλου, Athanasios Douzenis, Argyro Mazioti and M. Papathanasiou and has published in prestigious journals such as PLoS ONE, Schizophrenia Research and Progress in Neuro-Psychopharmacology and Biological Psychiatry.

In The Last Decade

E. Laskos

9 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Laskos Greece	8	271	196	136	84	82	9	398
Özlem Donat Eker Türkiye	9	184 0.7×	190 1.0×	83 0.6×	73 0.9×	57 0.7×	18	419
Feng-Chang Yen Taiwan	10	215 0.8×	124 0.6×	57 0.4×	100 1.2×	67 0.8×	11	446
Michelle L. Kloc United States	11	316 1.2×	213 1.1×	90 0.7×	58 0.7×	16 0.2×	22	527
Yumiko Akamine Finland	6	248 0.9×	168 0.9×	71 0.5×	45 0.5×	38 0.5×	10	414
Adrienne N. Santiago United States	7	147 0.5×	78 0.4×	145 1.1×	107 1.3×	58 0.7×	7	416
Rodrigo Nieto Chile	6	106 0.4×	75 0.4×	48 0.4×	83 1.0×	38 0.5×	12	301
Lauren M. Reynolds Canada	12	289 1.1×	121 0.6×	84 0.6×	39 0.5×	19 0.2×	24	490
Peter Flagstad Denmark	5	280 1.0×	110 0.6×	68 0.5×	88 1.0×	13 0.2×	6	435
Masahiko Tsunoda Japan	13	145 0.5×	141 0.7×	35 0.3×	29 0.3×	35 0.4×	23	409
Zhiguang Lin China	8	99 0.4×	63 0.3×	27 0.2×	109 1.3×	73 0.9×	12	326

Countries citing papers authored by E. Laskos

Since Specialization

Citations

This map shows the geographic impact of E. Laskos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Laskos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Laskos more than expected).

Fields of papers citing papers by E. Laskos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Laskos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Laskos. The network helps show where E. Laskos may publish in the future.

Co-authorship network of co-authors of E. Laskos

This figure shows the co-authorship network connecting the top 25 collaborators of E. Laskos. A scholar is included among the top collaborators of E. Laskos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Laskos. E. Laskos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Hatziagelaki, Erifili, Anastasia Tsiavou, George D. Vavougios, et al.. (2019). Effects of olanzapine on cytokine profile and brain-derived neurotrophic factor in drug-naive subjects with first-episode psychosis. Experimental and Therapeutic Medicine. 17(4). 3071–3076. 21 indexed citations

Rizos, Emmanouil�, Matilda Papathanasiou, E. Laskos, et al.. (2014). A Longitudinal Study of Alterations of Hippocampal Volumes and Serum BDNF Levels in Association to Atypical Antipsychotics in a Sample of First-Episode Patients with Schizophrenia. PLoS ONE. 9(2). e87997–e87997. 31 indexed citations

Rizos, Emmanouil�, M. Papathanasiou, Panayiota G. Michalopoulou, et al.. (2011). Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients. Schizophrenia Research. 129(2-3). 201–204. 66 indexed citations

Rizos, Emmanouil�, Panayiota G. Michalopoulou, Nikolaos Siafakas, et al.. (2010). Association of Serum Brain-Derived Neurotrophic Factor and Duration of Untreated Psychosis in First-Episode Patients with Schizophrenia. Neuropsychobiology. 62(2). 87–90. 46 indexed citations

Rizos, Emmanouil�, et al.. (2010). Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics. The World Journal of Biological Psychiatry. 11(2-2). 251–255. 97 indexed citations

Siafakas, Nikolaos, Nicholas C. Stefanis, Athanasios Douzenis, et al.. (2009). Association of serum BDNF and val66met polymorphism of the brain-derived neurotrophic factor in a sample of first psychotic episode patients.. PubMed. 20(4). 297–304. 13 indexed citations

Rizos, Emmanouil�, E. Laskos, George Arsenis, et al.. (2008). Investigation of serum BDNF levels in drug-naive patients with schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(5). 1308–1311. 105 indexed citations

Rizos, Emmanouil�, et al.. (2008). Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics. The World Journal of Biological Psychiatry. 1–5. 15 indexed citations

Rizos, Emmanouil�, et al.. (2008). DECREASED SERUM LEVELS OF BDNF IN FIRST EPISODE PATIENTS WITH SCHIZOPHRENIA AND ITS PSYCHOPATHOLOGICAL CORRELATIONS. Schizophrenia Research. 102(1-3). 208–209. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact